Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tipo Año Título Fuente
Artículo2024A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2024A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli diseaseJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2024Evaluation of temocillin efficacy against KPC-2-producing Klebsiella pneumoniae isolates in a hollow-fibre infection model.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2024Implications of two-component systems EnvZ/OmpR and BaeS/BaeR in in vitro temocillin resistance in Escherichia coli.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2024Influence of the COVID-19 pandemic on the defined daily dose of antimicrobials in patients requiring elective and emergency surgical proceduresJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2024Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2023Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIVJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2023Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2023Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trialJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2023Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practiceJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2023Stability of temocillin in outpatient parenteral antimicrobial therapy: is it a real option?JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2023Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimensJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2022Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobialsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2022Defining the scope of the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet): a bottom-up and One Health approachJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2022Effect of RecA inactivation and detoxification systems on the evolution of ciprofloxacin resistance in Escherichia coli.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2022Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2022In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing EnterobacteralesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGSJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemasesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Effect of RecA inactivation on quinolone susceptibility and the evolution of resistance in clinical isolates of Escherichia coliJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Efficacy of dual carbapenem treatment in a murine sepsis model of infection due to carbapenemase-producing Acinetobacter baumanniiJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countriesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Infections after spine instrumentation: effectiveness of short antibiotic treatment in a large multicentre cohort.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021Reporting antimicrobial susceptibilities and resistance phenotypes in Staphylococcus spp.: a nationwide proficiency study.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020A comparative study between real-time PCR and loop-mediated isothermal amplification to detect carbapenemase and/or ESBL genes in Enterobacteriaceae directly from bronchoalveolar lavage fluid samplesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophiliaJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020An evidence-based bundle improves the quality of care and outcomes of patients with candidaemiaJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohortJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Contribution of hypermutation to fosfomycin heteroresistance in Escherichia coliJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coliJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH projectJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in DenmarkJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in SpainJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Repositioning rafoxanide to treat Gram-negative bacilli infectionsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020Role of low-level quinolone resistance in generating tolerance in Escherichia coli under therapeutic concentrations of ciprofloxacinJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networksJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networksJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019Antimicrobial management of Tropheryma whipplei endocarditis: the Spanish Collaboration on Endocarditis (GAMES) experienceJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide surveyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019Epidemiology of MRSA CC398 in hospitals located in Spanish regions with different pig-farming densities: a multicentre studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trialJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community careJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass seriesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemiaJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiologyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coliJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2018Evaluation of the impact of a nationwide massive online open course on the appropriate use of antimicrobialsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2018Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedureJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2018Peptidoglycan recycling contributes to intrinsic resistance to fosfomycin in Acinetobacter baumanniiJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2018Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: a nationwide proficiency studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2018Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2018Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosisJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2018Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extendedspectrum- beta-lactamase-producing EnterobacteriaceaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir responseJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017ESGAP inventory of target indicators assessing antibiotic prescriptions: A cross-sectional surveyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017Etest (R) versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017Genotypic susceptibility score (GSS) and CD4+T cell recovery in HIV-1 patients with suppressed viral loadJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trialJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureusJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to EnterobacteriaceaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017Molecular insights into fosfomycin resistance in Escherichia coliJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017Pharmacokinetic interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2017Quantitative and automated MALDI-TOF MS-based detection of the plasmid-mediated quinolone resistance determinant AAC(6 ')-Ib-cr in EnterobacteriaceaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017Rapid detection of the plasmid-mediated quinolone resistance determinant AAC(6 ')-Ib-cr in Enterobacteriaceae by MALDI-TOF MS analysisJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2016Assessment of a phenotypic algorithm to detect plasmid-mediated quinolone resistance in EnterobacteriaceaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2016Characterization of an outbreak due to CTX-M-15-producing Klebsiella pneumoniae lacking the bla(OXA-48) gene belonging to clone ST405 in a neonatal unit in southern SpainJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2016CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in SpainJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2016Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2016Impact of AAC(6 ')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coliJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2016Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC projectJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2016Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2016Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonatesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2015Challenges to accurate susceptibility testing and interpretation of quinolone resistance in Enterobacteriaceae: results of a Spanish multicentre studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2015Effect of the efflux pump QepA2 combined with chromosomally mediated mechanisms on quinolone resistance and bacterial fitness in Escherichia coliJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2015Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2015Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2015Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2015Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-beta-lactamase-producing Klebsiella oxytocaJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2015Rates of faecal colonization by carbapenemase-producing Enterobacteriaceae among patients admitted to ICUs in SpainJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2015Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumpsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenemsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin systemJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014Determining accurate vancomycin MIC values for methicillin-resistant Staphylococcus aureus by the microdilution methodJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2014Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycinJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implicationsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitisJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coliJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohortJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2014Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort-authors' responseJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014Temporal trends in the discontinuation of first-line antiretroviral therapyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014TNF-alpha levels in HIV-infected patients after long-term suppressive cART persist as high as in elderly, HIV-uninfected subjectsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2014Within-lineage variability of ST131 Escherichia coli isolates from humans and companion animals in the south of EuropeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2013A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2013Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and beta-haemolytic streptococci collected from western European countries in 2011JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2013Challenges for accurate susceptibility testing, detection and interpretation of -lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2013Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum--lactamase-producing Klebsiella pneumoniaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2013Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83LeuJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2013Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infectionsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2013Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemiaJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Revisión2013Progress on the development of rapid methods for antimicrobial susceptibility testingJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2013Rapid detection of antibiotic resistance in Acinetobacter baumannii using quantitative real-time PCRJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2012Association between the IL28B genotype and hepatitis C viral kinetics in the early days of treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected patients with genotype 1 or 4JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2012Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureusJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2012Exposure to diverse antimicrobials induces the expression of qnrB1, qnrD and smaqnr genes by SOS-dependent regulationJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2012Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivoJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2012Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2012More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection ratesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2011Discrepancies in fluoroquinolone clinical categories between the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI for Escherichia coli harbouring qnr genes and mutations in gyrA and parCJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011Drug resistance mutations in patients infected with HIV-2 living in SpainJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza AJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis CJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2011Molecular characterization of high-level fluoroquinolone resistance in a clinical isolate of Haemophilus parainfluenzaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in SpainJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2011Similarities between the genetic environments of bla(CTX-M-15) in Escherichia coli from clinical and food samples from Spain and overseas travellersJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2010Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirinJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2010Characterization of fluoroquinolone resistance in a clinical isolate of Pseudomonas stutzeriJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2010Isolation of multidrug-resistant Klebsiella oxytoca carrying bla(IMP-8), associated with OXY hyperproduction, in the intensive care unit of a community hospital in SpainJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2010Quorum-sensing regulator sdiA and marA overexpression is involved in vitro-selected multidrug resistance of Escherichia coliJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2010Smaqnr, a new chromosome-encoded quinolone resistance determinant in Serratia marcescensJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2009Comment on: Redefining extended-spectrum beta-lactamases: balancing science and clinical needJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2009Correlation between the Trofile (R) test and virological response to a short-term maraviroc exposure in HIV-infected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2009Disruption of d-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the beta-lactam resistance modifier (-)-epicatechin gallateJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2009Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infectionJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2009Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosisJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2009Mutational analysis of quinolone resistance in the plasmid-encoded pentapeptide repeat proteins QnrA, QnrB and QnrSJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008Activity of BAL 4815 against filamentous fungiJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeastsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Corrección2008Effect of replacing glutamic residues upon the biological activity and stability of the circular enterocin AS-48 (vol 61, pg 1256, 2008)JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimenJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backboneJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiologyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008False extended-spectrum beta-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acidJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohortJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosisJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis:: a matched cohort studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008Qnr-like pentapeptide repeat proteins in Gram-positive bacteriaJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2007Evaluation of the Etest method for fosfomycin susceptibility of ESBL-producing Klebsiella pneumoniaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2007Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2007Interspecies spread of CTX-M-32 extended-spectrum β-lactamase and the role of the insertion sequence IS1 in down-regulating blaCTX-M gene expressionJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Revisión2007Liver toxicity induced by non-nucleoside reverse transcriptase inhibitorsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2007Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2007Molecular characterization of the gene encoding a new AmpC β-lactamase in Acinetobacter baylyiJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2006Characterization of a clinical isolate of Haemophilus influenzae with a high level of fluoroquinolone resistanceJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2006Comparative study of disc diffusion and microdilution methods in susceptibility testing of micafungin against Candida speciesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2006Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimenJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2006Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimenJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2006Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis CJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2006Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavirJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2006Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactamJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2006Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumanniiJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2006Survival and resistance to imipenem of Pseudomonas aeruginosa on latex glovesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2005Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillinJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2005Hyperproduction of AmpC beta-lactamase in a clinical isolate of Escherichia coli associated with a 30 bp deletion in the attenuator region of ampCJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2005Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2005Uptake and intracellular activity of voriconazole in human polymorphonuclear leucocytesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2005Vibrionaceae as a possible source of Qnr-like quinolone resistance determinantsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2004A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2004Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2004Antibiotic resistance in 3113 blood isolates of Staphylococcus aureus in 40 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2000-2002)JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2004Characterization of the first CTX-M-14-producing Salmonella enterica serotype Enteritidis isolateJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2004Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2003Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2003Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot studyJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2003Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2003Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamaseJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2003Interaction of plasmid and host quinolone resistanceJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2003Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adultsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2003Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumanniiJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2002Susceptibility patterns of bacteria causing community-acquired respiratory infections in Spain: the SAUCE projectJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2001Cefepime versus cefotaxime for empirical treatment of bacterial pneumonia in HIV-infected patients: an open, randomized trialJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2001Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strainsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2000Activity of nine antimicrobial agents against clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and deficient or not in porinsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2000Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agentsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2000Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumoniaJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2000Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniaeJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2000Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibioticsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2000Trends in the susceptibilities of Proteus mirabilis isolates to quinolonesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1999A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1999In-vitro activity of levofloxacin, ofloxacin and d-ofloxacin against coryneform bacteria and listeria monocytogenes.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter1997Azithromycin uptake by tissue cultured epithelial cellsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter1997Comparison of three methods of determining the in-vitro susceptibilities of Acinetobacter baumannii isolates to imipenem [7]JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter1997In-vitro susceptibilities of multiresistant strains of Acinetobacter baumannii to eight quinolonesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1996Comparative in-vitro activity of sparfloxacin against genital pathogensJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1996Effect of paclitaxel alone or in combination on the intracellular penetration and activity of quinolones in human neutrophilsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter1996Efficacy and safety of teicoplanin in infections caused by methicillin-resistant Staphylococcus aureusJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter1996In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumanniiJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Nota1995ACTIVITY OF SPARFLOXACIN ON STAPHYLOCOCCUS-EPIDERMIDIS ATTACHED TO PLASTIC CATHETERSJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1995FACTORS AFFECTING THE INTRACELLULAR ACCUMULATION AND ACTIVITY OF AZITHROMYCINJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Nota1994EFFECTS OF ANTIMICROBIAL AND ANTINEOPLASTIC DRUGS ON THE UPTAKE OF SPARFLOXACIN BY HUMAN NEUTROPHILSJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1991EFFECT OF ANTIMICROBIAL AGENTS ON THE UPTAKE OF OFLOXACIN AND ITS OPTICALLY-ACTIVE ISOMER (-)-OFLOXACIN BY HUMAN POLYMORPHONUCLEAR LEUKOCYTESJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1988INTERACTION OF AMINOGLYCOSIDES AND CEPHALOSPORINS AGAINST PSEUDOMONAS-AERUGINOSA - CORRELATION BETWEEN INTERACTION INDEX AND KILLING CURVEJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter1987COMPARATIVE INVITRO ACTIVITY OF CEFODIZIME, CEFPIROME, CARUMONAM AND RU-28965 WITH OTHER ANTIMICROBIALS AGAINST ANAEROBESJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1984COMPARATIVE ACTIVITY OF IMIPENEM (N-FORMIMIDOYL THIENAMYCIN) ON ENTEROCOCCI AND ITS INTERACTIONS WITH AMINOGLYCOSIDESJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1981N-FORMIMIDOYL-THIENAMYCIN ACTIVITY AGAINST ANAEROBES - EFFECT OF THE INOCULUM, PH AND CULTURE MEDIAJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1980SYNERGY BETWEEN CEFOTAXIME, CEFSULODIN, AZLOCILLIN, MEZLOCILLIN AND AMINOGLYCOSIDES AGAINST CARBENICILLIN RESISTANT OR SENSITIVE PSEUDOMONAS-AERUGINOSAJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo1978CEFOXITIN SODIUM ACTIVITY AGAINST ANAEROBES - EFFECT OF INOCULUM SIZE, PH VARIATION AND DIFFERENT CULTURE MEDIAJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY